Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation

Connective Tissue Research

Volumn 52, Issue 5, 2011, Pages 401-407

  Igwe, John C ^a   Gao, Qi ^a   Kizivat, Tomislav ^a   Kao, Winston W ^b   Kalajzic, Ivo ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

differentiation; keratocan; osteoblast; osteocyte

Indexed keywords

BONE SIALOPROTEIN; KERATOCAN; MESSENGER RNA; OSTEOCALCIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BONE DEVELOPMENT; CELL DIFFERENTIATION; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCYTES; OSTEOGENESIS; PROTEOGLYCANS; RNA, MESSENGER; SKULL;

MUS;

EID: 80052771872     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2010.546536     Document Type: Article

References (28)

1. Tasheva, E., Koester, A., Paulsen, A., Garrett, A., Boyle, D., Davidson, H., Song, M., Fox, N., and Conrad, G. (2002).Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol. Vis. 8:407-415. (Pubitemid 36153631)
2. Kalamajski, S., and Oldberg, A. (2010).The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 29:248-253.
3. Raouf, A., Ganss, B., McMahon, C., Vary, C., Roughley, P., and Seth, A. (2002).Lumican is a major proteoglycan component of the bone matrix. Matrix Biol. 21:361-367. (Pubitemid 34786472)
4. Sinha, R., and Tuan, R. (1996).Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 18:451-457. (Pubitemid 26152308)
5. Paic, F., Igwe, J., Nori, R., Kronenberg, M., Franceschetti, T., Harrington, P., Kuo, L., Shin, D., Rowe, D., Harris, S., and Kalajzic, I. (2009).Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45:682-692.
6. Liu, C., Birk, D., Hassell, J., Kane, B., and Kao, W. (2003).Keratocan-deficient mice display alterations in corneal structure. J. Biol. Chem. 278:21672-21677. (Pubitemid 36792568)
7. Kao, W., and Liu, C. (2003).The use of transgenic and knock-out mice in the investigation of ocular surface cell biology. Ocul. Surf. 1:5-19. (Pubitemid 41263853)
8. Hocking, A., Shinomura, T., and McQuillan, D. (1998).Leucinerich repeat glycoproteins of the extracellular matrix. Matrix Biol. 17:1-19. (Pubitemid 28206020)
9. Ameye, L., and Young, M. (2002).Mice deficient in small leucine- rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R-116R.
10. Bianco, P., Fisher, L., Young, M., Termine, J., and Robey, P. (1990).Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38:1549-1563. (Pubitemid 20346965)
11. Bi, Y., Stuelten, C., Kilts, T., Wadhwa, S., Iozzo, R., Robey, P., Chen, X., and Young, M. (2005).Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J. Biol. Chem. 280:30481-30489. (Pubitemid 41216232)
12. Goldberg, M., Ono, M., Septier, D., Bonnefoix, M., Kilts, T., Bi, Y., Embree, M., Ameye, L., and Young, M. (2009).Fibromodulin- deficient mice reveal dual functions for fibromodulin in regulating dental tissue and alveolar bone formation. Cells Tissues Organs 189:198-202.
13. Carlson, E., Wang, I., Liu, C., Brannan, P., Kao, C., and Kao, W. (2003).Altered KSPG expression by keratocytes following corneal injury. Mol. Vis. 9:615-623. (Pubitemid 38097627)
14. Michelacci, Y. (2003).Collagens and proteoglycans of the corneal extracellular matrix. Braz. J. Med. Biol. Res. 36:1037-1046. (Pubitemid 37080914)
15. Rees, S.G., Waggett, A.D., Kerr, B.C., Probert, J., Gealy, E.C., Dent, C.M., Caterson, B., and Hughes, C.E. (2009).Immunolocalisation and expression of keratocan in tendon. Osteoarthr. Cartil. 17:276-279.
16. Kalajzic, I., Braut, A., Guo, D., Jiang, X., Kronenberg, M.S., Mina, M., Harris, M.A., Harris, S.E., and Rowe, D.W. (2004).Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35:74-82. (Pubitemid 38789150)
17. Kalajzic, I., Kalajzic, Z., Kaliterna, M., Gronowicz, G., Clark, S.H., Lichtler, A.C., and Rowe, D. (2002).Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res. 17:15-25. (Pubitemid 33150992)
18. Kalajzic, I., Terzic, J., Rumboldt, Z., Mack, K., Naprta, A., Ledgard, F., Gronowicz, G., Clark, S., and Rowe, D. (2002).Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology 143:1594-1601. (Pubitemid 34415873)
19. Wong, G., and Cohn, D. (1975).Target cells in bone for parathormone and calcitonin are different: Enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc. Natl. Acad. Sci. U.S.A. 72:3167-3171.
20. Celeste, A., Rosen, V., Buecker, J., Kriz, R., Wang, E., and Wozney, J. (1986).Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J. 5:1885-1890.
21. Young, M., Ibaraki, K., Kerr, J., Lyu, M., and Kozak, C. (1994).Murine bone sialoprotein (BSP): cDNA cloning, mRNA expression, and genetic mapping. Mamm. Genome 5:108-111. (Pubitemid 2051288)
22. Kalajzic, I., Kalajzic, Z., Kaliterna, M., Gronowicz, G., Clark, S., Lichtler, A., and Rowe, D. (2002).Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res. 17:15-25. (Pubitemid 33150992)
23. Parfitt, A., Villanueva, A., Foldes, J., and Rao, D. (1995).Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis. J. Bone Miner. Res. 10:466-473.
24. Rees, S., Dent, C., and Caterson, B. (2009).Metabolism of proteoglycans in tendon. Scand. J. Med. Sci. Sports 19:470-478.
25. Wilda, M., Bächner, D., Just, W., Geerkens, C., Kraus, P., Vogel, W., and Hameister, H. (2000).A comparison of the expression pattern of five genes of the family of small leucinerich proteoglycans during mouse development. J. Bone Miner. Res. 15:2187-2196.
26. Wadhwa, S., Embree, M., Ameye, L., and Young, M. (2005).Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs 181:136-143.
27. Wadhwa, S., Embree, M., Kilts, T., Young, M., and Ameye, L. (2005).Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthr. Cartil. 13:817-827. (Pubitemid 41263940)
28. Douglas, T., Heinemann, S., Bierbaum, S., Scharnweber, D., and Worch, H. (2006).Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. Biomacromolecules 7:2388-2393. (Pubitemid 44336350)